1. Home
  2. NBY vs PNNT Comparison

NBY vs PNNT Comparison

Compare NBY & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$0.77

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

HOLD

Current Price

$5.67

Market Cap

397.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
PNNT
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
397.7M
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
NBY
PNNT
Price
$0.77
$5.67
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$5.95
AVG Volume (30 Days)
2.4M
634.5K
Earning Date
11-07-2025
02-09-2026
Dividend Yield
N/A
16.90%
EPS Growth
N/A
N/A
EPS
0.47
0.50
Revenue
$10,302,000.00
$122,377,000.00
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
N/A
P/E Ratio
$30.13
$11.33
Revenue Growth
390.34
N/A
52 Week Low
$0.46
$5.57
52 Week High
$19.95
$7.53

Technical Indicators

Market Signals
Indicator
NBY
PNNT
Relative Strength Index (RSI) 35.42 38.97
Support Level $0.75 $5.57
Resistance Level $2.13 $5.85
Average True Range (ATR) 0.58 0.11
MACD -0.61 -0.02
Stochastic Oscillator 0.26 20.93

Price Performance

Historical Comparison
NBY
PNNT

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: